Analysis of the tolerance and safety of inhaled antibiotics and hypertonic saline solution in patients with bronchial hyperreactivity
A. Perez Figuera (Madrid, Spain), R. Nieto Royo (Madrid, Spain), R. Morillo Guerrero (Madrid, Spain), C. Almonacid Sánchez (Toledo, Spain), A. Solier López (Madrid, Spain), E. Barbero Herranz (Madrid, Spain), D. Durán Barata (Madrid, Spain), B. Pintado Cort (Madrid, Spain), D. Velasco Álvarez (Madrid, Spain), L. Máiz Carro (Madrid, Spain)
Source: International Congress 2022 – Asthma treatment: real-world studies and other diseases
Rating: 
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
A. Perez Figuera (Madrid, Spain), R. Nieto Royo (Madrid, Spain), R. Morillo Guerrero (Madrid, Spain), C. Almonacid Sánchez (Toledo, Spain), A. Solier López (Madrid, Spain), E. Barbero Herranz (Madrid, Spain), D. Durán Barata (Madrid, Spain), B. Pintado Cort (Madrid, Spain), D. Velasco Álvarez (Madrid, Spain), L. Máiz Carro (Madrid, Spain). Analysis of the tolerance and safety of inhaled antibiotics and hypertonic saline solution in patients with bronchial hyperreactivity. 1346
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
|
|